Aranda Pharma Competitors and Similar CompaniesClear all

Aranda Pharma's competitors and similar companies include CytomX Therapeutics, Onxeo and Amolyt Pharma.
Aranda Pharma
Aranda Pharma
Aranda Pharma is a drug discovery company.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Onxeo
Onxeo
Onxeo is biotechnology company that develops of drugs for oncology.
Amolyt Pharma
Amolyt Pharma
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
1997
Founding Date
2015
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Kuopio, FI HQ
Locations
South San Francisco, US HQ
Locations
Paris, FR HQ
New York, US
Locations
Écully, FR HQ
Cambridge, US
Employees
Employees
5
Employees
15815% increase
Employees
30
Employees
605% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
145.6 m
Valuation ($)
65 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
947
Twitter followers
166

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 132.4m
Total funding raised
N/A
Total funding raised
$ 93.1m
For sources of this data, please see the company profile

View Company Profiles

CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
Onxeo
HQ
Paris, FR
Employees
30

Onxeo is biotechnology company that develops of drugs for oncology.

View company
Amolyt Pharma
HQ
Écully, FR

Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.

View company